Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region

Arthritis and Rheumatism

Volumn 42, Issue 11, 1999, Pages 2482-2488

  Offenbaecher, Martin ^a   Bondy, Brigitta ^a   De Jonge, Silvia ^a   Glatzeder, Karin ^a   Krüger, Marc ^a   Schoeps, Peter ^a   Ackenheil, Manfred ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN; SEROTONIN TRANSPORTER;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISTRESS SYNDROME; FEMALE; FIBROMYALGIA; GENETIC ANALYSIS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; SEROTONIN METABOLISM; SYMPTOMATOLOGY;

ADULT; AGED; CARRIER PROTEINS; FEMALE; FIBROMYALGIA; GENE FREQUENCY; GENETIC MARKERS; GENOTYPE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; POLYMORPHISM, GENETIC; REGULATORY SEQUENCES, NUCLEIC ACID; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 0033513129     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199911)42:11<2482::AID-ANR27>3.0.CO;2-B     Document Type: Article

References (49)

1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 1990;33:160-72.
2. Wolfe F, Russell IJ, Vipraio G, Ross K, Anderson J. Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population. J Rheumatol 1997;24:555-9.
3. Russell IJ, Michalek JE, Vipraio GA, Fletcher EM, Wall K. Serum amino acids in fibrositis/fibromyalgia syndrome [abstract]. Arthritis Rheum 1989;32 Suppl 4:S70.
4. Yunus MB, Dailey JW, Aldag JC, Masi AT, Jobe PC. Plasma tryptophan and other amino acids in primary fibromyalgia: a controlled study. J Rheumatol 1992;19:90-4.
5. Stratz T, Samborski W, Hrycaj P, Pap T, Mackiewicz S, Mennet P, et al. Die Serotonin - konzentration im Serum bei Patienten mit generalisierter Tendomyopathie (Fibromyalgie) und chronischer Polyarthritis. Med Klin 1993;88:458-62.
6. Houvenagel E, Forzy G, Cortet B, Vincent G. 5-hydroxy indol acetic acid in cerebro spinal fluid in fibromyalgia [abstract]. Arthritis Rheum 1990;33 Suppl 9:S55.
7. Russell IJ, Vaeroy H, Javors M, Nyberg F. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 1992;35:550-6.
8. Bakish D, Cavazzoni P, Chudzik J, Ravindran A, Hrdina PD. Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder. Biol Psychiatry 1997;41:184-90.
9. Coccaro EF, Kavoussi RJ, Sheline YI, Lish JD, Csernansky JG. Impulsive aggression in personality disorder correlates with tritiated paroxetine binding in the platelet. Arch Gen Psychiatry 1996;53:531-6.
10. Fichtner CG, O'Connor FL, Yeoh HC, Arora RC, Crayton JW. Hypodensity of platelet serotonin uptake sites in posttraumatic stress disorder: associated clinical features. Life Sci 1995;57:37-44.
11. Russell IJ, Michalek JE, Vipraio GA, Fletcher EM, Javors MA, Bowden CA. Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol 1992;19:104-9.
12. Kravitz HM, Katz R, Kot E, Helmke N, Fawcett J. Biochemical clues to a fibromyalgia depression link: imipramine binding in patients with fibromyalgia or depression and in healthy controls. J Rheumatol 1992;19:1428-32.
13. Heils A, Teufel A, Petri S, Stöber G, Riederer P, Bengel D, et al. Allelic variation of human serotonin transporter gene expression. J Neurochem 1996;66:2621-4.
14. Collier DA, Arranz MJ, Sham P, Battersby S, Vallada H, Gill P, et al. The serotonin transporter is a potential susceptibility factor for bipolar affective disorders. Neurol Rep 1996;7:1675-9.
15. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996;274: 1527-31.
16. Li T, Holmes C, Sham PC, Vallada H, Birkett J, Kirov G, et al. Allelic functional variation of serotonin transporter expression is susceptibility factor for late Alzheimer's disease. Neurol Rep 1997;8:683-6.
17. Klauck SM, Poustka F, Benner A, Lesch KP, Poustka A. Serotonin transporter (5-HTT) gene variants associated with autism. Hum Mol Genet 1997;6:2233-8.
18. Sander T, Harms H, Lesch KP, Dufeu P, Kuhn S, Hoehe M, et al. Association analysis of a regulatory variation of the serotonin transporter gene with severe alcohol dependence. Alcohol Clin Exp Res 1997;21:1356-9.
19. Ogilvie AD, Russell MB, Dhall P, Battersby S, Ulrich V, Dale Smith CA, et al. Altered allelic distributions of the serotonin transporter gene in migraine without aura and migraine with aura. Cephalalgia 1998;18:23-6.
20. Hanna GL, Himle JA, Curtis GC, Koram DQ, Weele JVV, Leventhal BL, et al. Serotonin transporter and seasonal variation in blood serotonin in families with obsessive-compulsive disorders. Neuropsychopharmacology 1998;18:102-11.
21. Butcher JN, Dahlstrom WG, Graham JR, Tellegen A, Kaemmer B. Minnesota Multiphasic Personality Inventory (MMPI-2) manual for administering and scoring. Minneapolis: University of Minnesota Press; 1989.
22. Costa PT, McCrae RR. Revised NEO Personality Inventory (NEO PI-R) and NEO Five Factor Inventory: professional manual. Odessa: Psychological Assessment Resources; 1992.
23. Cloninger CR. A systematic method for clinical description and classification of personality variants. Arch Gen Psychiatry 1987; 44:573-88.
24. Burckhardt CS, O'Reilly CO, Wiens AN, Clark SR, Campbell SM, Bennett RM. Assessing depression in fibromyalgia patients. Arthritis Care Res 1994;7:35-9.
25. Hautzinger M, Bailer M, Worall H, Keller F. Beck Depressions-inventar (BDI). Bern: Hans Huber; 1995.
26. Uveges JM, Parker JC, Smarr KL, McGowan JF, Lyon MG, Irvin WS, et al. Psychological symptoms in primary fibromyalgia syndrome: relationship to pain, life stress, and sleep disturbance. Arthritis Rheum 1990;33:1279-83.
27. Franke GH. Die Symptom-Checkliste von Derogatis (Deutsche Version). Göttingen (Germany): Beltz Test; 1995.
28. Salomon RM, Delgado PL, Licinio J, Krystal JH, Heninger GR, Charney DS. Effects of sleep deprivation on serotonin function in depression. Biol Psychiatry 1994;36:840-6.
29. Stockmeier CA. Neurobiology of serotonin in depression and suicide. Ann N Y Acad Sci 1997;836:220-32.
30. Collier DA, Stober G, Li T. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry 1996;1: 453-60.
31. Heils A, Teufel A, Petri S. Functional promoter and polyadenylation site mapping of the human serotonin (5-HT) transporter gene. J Neural Transm 1995;102:247-54.
32. Little KY, McLaughlin DP, Zhang L. Brain dopamine transporter messenger RNA and binding sites in cocaine users: a postmortem study. Arch Gen Psychiatry 1998;55:793-9.
33. Lesch KP, Mossner R. Genetically driven variation in serotonin uptake: is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders? Biol Psychiatry 1998;44:179-92.
34. Nakamura T, Muramatsu T, Ono Y. Serotonin transporter gene regulatory region polymorphism and anxiety-related traits in the Japanese. Am J Med Genet 1997;74:544-5.
35. Billett EA, Richter MA, King N, Heils A, Lesch KP, Kennedy JL. Obsessive compulsive disorder: response to serotonin reuptake inhibitors and the serotonin transporter gene. Mol Psychiatry 1997;2:403-6.
36. Hudson JI, Goldenberg DL, Pope HG, Keck PE, Schlesinger L. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 1992;92:363-7.
37. Buskila D, Neumann L, Hazanov I, Carmi R. Familial aggregation in the fibromyalgia syndrome. Semin Arthritis Rheum 1996;26: 605-11.
38. Buskila DA, Neumann L. Fibromyalgia syndrome (FM) and nonarticular tenderness in relatives of patients with FM. J Rheumatol 1997;24:941-4.
39. Offenbächer M, Glatzeder K, Ackenheil M. Self-reported depression, family history of depression and fibromyalgia in patients with fibromyalgia. Z Rheumatol 1998;57:94-6.
40. Katz RS, Kravitz HM. Fibromyalgia, depression, and alcoholism: a family history study. J Rheumatol 1996;23:149-54.
41. Crow TJ. Survey of cases of familial mental illness. Eur Arch Psychiatry Clin Neurosci 1991;240:314-24.
42. Ackenheil M. The mechanism of action of antidepressants revised. J Neural Transm 1990;32:29-37.
43. Goldenberg D, Mayskiy M, Mossey C, Ruthazer R, Schmid C. A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum 1996; 39:1852-9.
44. Hudson Jl, Pope HG. Fibromyalgia and psychopathology: is fibromyalgia a form of "affective spectrum disorder"? J Rheumatol 1989;16:15-22.
45. Yunus MB. Psychological aspects of fibromyalgia syndrome: a component of the dysfunctional spectrum syndrome. Baillieres Clin Rheumatol 1994;9:811-37.
46. Yunus MB. Towards a model of pathophysiology of fibromyalgia: aberrant central pain mechanism with peripheral modulation. J Rheumatol 1992;19:846-50.
47. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC): American Psychiatric Association; 1994.
48. Bondy B, Späth M, Offenbächer M, Glatzeder K, Stratz T, Schwarz M, et al. The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia. Neurobiol Dis 1999;7:1-7.
49. Yunus MB, Khan MA, Rawlings KK, Green JR, Olson JM, Shah S. Genetic linkage analysis of multicase families with fibromyalgia syndrome. J Rheumatol 1999;26:408-12.